Financials

	2021	2022
Net sales	-	-
Net income	-3.66Cr -2.57Cr -2.28Cr -2.14Cr -1.94Cr -248.04Cr -3.69Cr -26Cr -9.98Cr -126.53Cr -9.66Cr -9.45Cr -406.78Cr	-3.8Cr -2.67Cr -2.37Cr -2.22Cr -2.01Cr -257.54Cr -3.83Cr -27Cr -10Cr -131.38Cr -10Cr -9.81Cr -422.37Cr
Net Debt	-1.9Cr -1.33Cr -1.18Cr -1.11Cr -1Cr -128.54Cr -1.91Cr -13Cr -5.17Cr -66Cr -5.01Cr -4.9Cr -210.81Cr	76.74L 53.97L 47.91L 44.83L 40.63L 52Cr 77.3L 5.38Cr 2.09Cr 27Cr 2.03Cr 1.98Cr 85Cr

Company Profile

IMV Inc. is a Canada-based company. The Company has sold all of its assets. It is not engaged in any business operations.

Employees

Sector

Date	Price	Change	Volume
05/26/05	$0.000001	0.00%	1,020

Delayed Quote OTC Markets

Market Closed - OTC Markets 09:33:15 05/10/2026 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

24/24/24	OPEC excited about Namibia partnership, offers support	RE
16/23/16	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023

24/24/24	OPEC excited about Namibia partnership, offers support	RE
16/23/16	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
11/22/11	IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022
11/22/11	IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022
29/22/29	IMV Inc. - Shareholder/Analyst Call

04/23/04	IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	AQ
14/19/14	IMV Inc. : to Present at Two Upcoming Investor Conferences	BU
12/19/12	Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	BU

Manager	Title	Age	Since
Stéphane Fiset CTO	Chief Tech/Sci/R&D Officer	-	-
Tracy Sherren SEC	Corporate Secretary	60	-
Marie-Eve Charrois LAW	General Counsel	-	-

Director	Title	Age	Since
Markus Warmuth BRD	Director/Board Member	55	06/11/2018
Michael Bailey CHM	Chairman	60	01/05/2022
Michael Kalos BRD	Director/Board Member	64	11/05/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
06/04/23	Shabnam Kazmi	Option	Director	48,259	0.4121%
06/04/23	Michael Kalos	Option	Director	52,378	0.4472%
06/04/23	Markus Warmuth	Option	Director	56,007	0.4782%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMV INC.	0.00%	0.00%	-	-	14
INVESTOR AB	-0.42%	+0.98%	+32.42%	+91.03%	13TCr
INDUSTRIVÄRDEN AB	-0.86%	-2.06%	+38.19%	+84.57%	2.26TCr
HAL TRUST	-0.24%	-0.37%	+20.74%	+50.93%	1.66TCr
MERITZ FINANCIAL GROUP INC.	+0.85%	-2.11%	+14.55%	+143.26%	1.56TCr
LUNDBERG B	-0.65%	-1.55%	+14.42%	+25.00%	1.42TCr
KINGDOM HOLDING COMPANY	0.00%	+3.27%	+70.97%	+98.86%	1.37TCr
INVESTMENT AB LATOUR	-0.66%	+0.84%	-11.81%	+7.26%	1.31TCr
BAJAJ HOLDINGS & INVESTMENT LIMITED	+0.89%	-0.63%	-10.38%	+56.82%	1.23TCr
WASHINGTON H. SOUL PATTINSON AND COMPANY LIMITED	+0.77%	-3.66%	+21.56%	+37.71%	1.21TCr
Average	+0.00%	-0.58%	+21.18%	+66.16%	2.45TCr
Weighted average by Cap.	-0.19%	-0.12%	+27.10%	+78.84%